A Pilot Trial of Stepwise Implementation of Virtual Reality Mindfulness and Accelerated Transcranial Magnetic Stimulation Treatments for Dysphoria in Neuropsychiatric Disorders

Table 5

Paired -tests of primary clinician and self-rated scales from TMS treatment B1 to TMS follow-up B1 across the entire sample.

Measure	Mean		Std. error mean difference	Mean difference			Sig. (2-tailed)
	TxB1	FxB1
PHQ-9	13.92	10.17	1.6382	3.7500	2.289	11	.043
GAD-7	11.58	8.17	1.3732	3.4167	2.488	11	.030
PCL-5	21.58	15.50	2.6953	6.0833	2.257	11	.045
PROMIS pain intensity	4.75	4.58	.2973	.1667	.561	11	.586
SF-36 emotional well-being	39.67	48.67	4.8273	-9.0000	-1.864	11	.089
MADRS	22.25	14.50	2.4898	7.7500	3.113	11	.010
HAM-A	17.33	9.58	2.9775	7.7500	2.603	11	.025
CAPS-5	17.75	11.58	2.9869	6.1667	2.065	11	.063
PROMIS pain interference	11.50	11.58	.9411	-.0833	-.089	11	.931